APA

Sumpter L. R., Inayat M. S., Yost E. E., Duvall W., Hagan E., Mayhew C. N., Elford H. L. & Gallicchio V. S. (20040802). In vivo examination of hydroxyurea and the novel ribonucleotide reductase inhibitors trimidox and didox in combination with the reverse transcriptase inhibitor abacavir: suppression of retrovirus-induced immunodeficiency disease. : Antiviral research.

Chicago

Sumpter L Ryan, Inayat Mohammed S, Yost Erin E, Duvall William, Hagan Espen, Mayhew Christopher N, Elford Howard L and Gallicchio Vincent S. 20040802. In vivo examination of hydroxyurea and the novel ribonucleotide reductase inhibitors trimidox and didox in combination with the reverse transcriptase inhibitor abacavir: suppression of retrovirus-induced immunodeficiency disease. : Antiviral research.

Harvard

Sumpter L. R., Inayat M. S., Yost E. E., Duvall W., Hagan E., Mayhew C. N., Elford H. L. and Gallicchio V. S. (20040802). In vivo examination of hydroxyurea and the novel ribonucleotide reductase inhibitors trimidox and didox in combination with the reverse transcriptase inhibitor abacavir: suppression of retrovirus-induced immunodeficiency disease. : Antiviral research.

MLA

Sumpter L Ryan, Inayat Mohammed S, Yost Erin E, Duvall William, Hagan Espen, Mayhew Christopher N, Elford Howard L and Gallicchio Vincent S. In vivo examination of hydroxyurea and the novel ribonucleotide reductase inhibitors trimidox and didox in combination with the reverse transcriptase inhibitor abacavir: suppression of retrovirus-induced immunodeficiency disease. : Antiviral research. 20040802.